English Deutsch 中文
  • Innovative Solutions
  • Expert Support and Knowledge
  • Reliable Cooperation
Menu Deutsch 中文

Kang Sheng Bao to Develop Immune System Diagnostic Test for SuperNova

Mar. 29, 2011

Shenzhen Kang Sheng Bao Bio-Technology (KSB) has signed an agreement with SuperNova Diagnostics, a Washington DC development stage company, giving KSB the China rights to develop, manufacture and market its diagnostic products that measure neopterin, which is a biomarker of immune system activity.